TRX818
TRX818 is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities. TRX-818, upon oral administration appears to induce cancer cell apoptosis and inhibits cancer cell proliferation. TRX818 also prevents tumor cell VM by blocking the formation of vasculogenic-like tubular structures.
Product Specifications
Shipping Conditions
gel pack
Storage Conditions
-20°C
Shelf Life
36 months
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1273664-01 0.01 mg Plasmid + 0.2 mL Glycerol-Stock
DERL2 cDNA Clone
Sign In for Pricing
View Details MBS1273664-02 5x 0.01 mg Plasmid + 5x 0.2 mL Glycerol-Stock
DERL2 cDNA Clone
Sign In for Pricing
View Details 
RC224384L1V 200 µL
ITIH2 (NM_002216) Human Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details